Sttar Mellison Pharmaceuticals Private Limited
Pharmaceutical company manufacturing, trading, and distributing various medical products for humans, animals, and insects.
2016 | Raigarh, Maharashtra (India) | Active
Sttar Mellison Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Revenue Growth 83.36%
- Profit Growth 191.40%
- Ebitda 102.33%
- Net Worth 1846.37%
- Total Assets 64.08%
About Sttar Mellison Pharmaceuticals
Sttar Mellison Pharmaceuticals Private Limited (SMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 June 2016 (Eight years and eight months 6 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹5.00 M.
Lalita Kalel and Shankar Tone serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2016PTC282801
- Company No.
282801
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Sttar Mellison Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalita Kalel  | Director | 23-Jun-2016 | Current |
| Shankar Tone | Director | 23-Jun-2016 | Current |
Financial Performance of Sttar Mellison Pharmaceuticals.
Sttar Mellison Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 83.36% increase. The company also saw a substantial improvement in profitability, with a 191.4% increase in profit. The company's net worth Soared by an impressive increase of 1846.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sttar Mellison Pharmaceuticals?
Unlock access to Sttar Mellison Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹5.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Others | ₹5.00 M | Open |
How Many Employees Work at Sttar Mellison Pharmaceuticals?
Unlock and access historical data on people associated with Sttar Mellison Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sttar Mellison Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sttar Mellison Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.